Measuring of spatial localizations of pyruvate-to-lactate and pyruvate-to-glutamate conversions signifies an important step to use HP [2–13C]pyruvate to investigate cerebral energy metabolism and potentially characterize brain tumors with isocitrate dehydrogenase (IDH) mutations. This evidence concerns the gene IDH1 and brain neoplasm.